Otonomy, Inc. Logo
Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting
January 23, 2020 07:30 ET | Otonomy, Inc.
SAN DIEGO, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
Otonomy, Inc. Logo
Otonomy Initiating Phase 1/2 Clinical Trial of OTO-413 in Hearing Loss
September 17, 2019 07:30 ET | Otonomy, Inc.
SAN DIEGO, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
Otonomy, Inc. Logo
Otonomy to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Corporate Update
February 25, 2019 16:05 ET | Otonomy, Inc.
SAN DIEGO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
Otonomy, Inc. Logo
Otonomy Holds Investor and Analyst Day and Provides Corporate Update
October 07, 2016 08:00 ET | Otonomy, Inc.
SAN DIEGO, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and...
Otonomy, Inc. Logo
Otonomy Reports Third Quarter 2015 Financial Results and Provides Corporate Update
November 10, 2015 16:21 ET | Otonomy, Inc.
SAN DIEGO, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Otonomy, Inc. Logo
Otonomy Appoints Dean Hakanson, M.D., as Chief Medical Officer
April 01, 2015 07:00 ET | Otonomy, Inc.
SAN DIEGO, April 1, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Otonomy, Inc. Logo
Otonomy Submits New Drug Application to the FDA for AuriPro(TM)
February 26, 2015 07:30 ET | Otonomy, Inc.
SAN DIEGO, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Otonomy, Inc. Logo
Otonomy to Present at the J.P. Morgan Healthcare Conference
January 06, 2015 08:00 ET | Otonomy, Inc.
SAN DIEGO, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...
Otonomy, Inc. Logo
Otonomy Added To Russell 2000(R) Index
October 01, 2014 08:00 ET | Otonomy, Inc.
SAN DIEGO, Oct. 1, 2014 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for...